Cell therapy-A 21st century hope for treating cardiovascular disease-A five-year retrospective and predictive view

American Heart Hospital Journal

Volumn 9, Issue 1, 2011, Pages 24-27

  Taylor, Doris A ^a  

^a Center for Cardiovascular Repair   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADIPOSE TISSUE CELL; ARTICLE; BLOOD CELL; BONE MARROW CELL; CARDIOVASCULAR DISEASE; CELL POPULATION; CELL THERAPY; DISEASE COURSE; EMBRYONIC STEM CELL; EUROPE; FIBROBLAST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; IN VIVO STUDY; INDUCED PLURIPOTENT STEM CELL; MYOBLAST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BIOLOGICAL THERAPY;

CARDIOVASCULAR DISEASES; HUMANS; RETROSPECTIVE STUDIES; TISSUE THERAPY;

EID: 84555195637     PISSN: 15419215     EISSN: 17517168     Source Type: Journal    
DOI: 10.15420/ahhj.2011.9.1.24     Document Type: Article

References (19)

1. Scacciatella P, Amato G, Ebrille E, et al. [Current perspectives in cell therapy in cardiology: an overview of ongoing trials], G Ital Cardiol (Rome), 2010;11(10):769-74
2. Cedars-Sinai Medical Center, Cardiosphere-Derived autologous Stem Cells to Reverse Ventricular Dysunction (CADUCEUS). Available at: http://clinicaltrials.gov/ct2/show/NCT00893360? term=00893360&rank=1 (Accessed 22 July 2011)
3. University of Louisville. Cardiac Stem Cell Infusion in Patients With Ischemic Cardiomyopathy (SCIPIO). Available at: http://clinicaltrials.gov/ct2/show/NCT00474461?term=00474461&ra nk=1 (Accessed 22 July 2011)
4. National Heart Lung and Blood Instititute. Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study). Available at: http://clinicaltrials.gov/ct2/show/NCT00684060?term=NCT0068406 0&rank=1 (Accessed 22 July 2011)
5. National Heart Lung and Blood Instititute. Use of Adult Autologous Stem Cells in Treating People Who Have Had a Heart Attack (The TIME Study). Available at: http://clinicaltrials.gov/ct2/show/NCT00684021 (Accessed 22 July 2011)
6. Cytori Therapeutics. A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non-Revascularizable Ischemic Myocardium (PRECISE-01). Available at: http://clinicaltrials.gov/ct2/show/NCT00076986?term=NCT00076986&rank=1 (Accessed 22 July 2011)
7. Losordo D, Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia (ACT34-CLI). Available at: http://clinicaltrials.gov/ct2/show/NCT00616980?term=NCT00616980&rank=1. (Accessed 22 July 2011)
8. Petersen JW, Forder JR, Thomas JD, et al. Quantification of Myocardial Segmental Function in Acute and Chronic Ischemic Heart Disease and Implications for Cardiovascular Cell Therapy Trials A Review From the NHLBI-Cardiovascular Cell Therapy Research Network, JACC Cardiovasc Imaging, 2011;4(6):671-9
9. Lucignani G, Rodriguez-Porcel M, In vivo imaging for stem cell therapy: new developments and future challenges, Eur J Nucl Med Mol Imaging, 2011;38(2):400-5
10. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 2006;126(4):663-76
11. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 2007;131(5):861-72
12. Vogel G, Holden C. Developmental biology. Field leaps forward with new stem cell advances, Science, 2007;318(5854):1224-5
13. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells, Science, 2007;318(5858):1917-20
14. Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution, Cell Stem Cell, 2007;1(1):55-70
15. Lengner CJ. iPS cell technology in regenerative medicine, Ann N Y Acad Sci, 2010;1192:38-44
16. Zenovich AG, Taylor DA. Atherosclerosis as a disease of failed endogenous repair, Front Biosci, 2008;13:3621-36
17. Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart, Nat Med, 2008;14(2):213-21
18. Baiguera S, Jungebluth P, Burns A, et al. Tissue engineered human tracheas for in vivo implantation, Biomaterials, 2010;31(34):8931-8
19. Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty, Lancet, 2006;367(9518):1241-6